CITR earnings analysis
What we found in CITR's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The provided 10-Q excerpt contains no income statement, balance sheet, cash flow, segment, or MD&A financial data, so current-period operating trends cannot be assessed. Management reported effective disclosure controls as of June 30, 2026 and no material internal-control changes during the quarter. The main disclosed financial event is the issuance of 408,334 common shares, including 33,333 shares valued at $282,997 and 375,001 shares issued on conversion of 112,500 preferred shares, creating dilution risk.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Disclosure controls deemed effective
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026, providing reasonable assurance over reporting and communication processes.
- No material control deterioration
- The company reported no material changes in internal control over financial reporting during the three months ended June 30, 2026.
- Capital structure activity disclosed
- CitroTech issued 408,334 unregistered common shares during the quarter, including 33,333 shares to consultants valued at $282,997 and 375,001 shares upon conversion of 112,500 Series C preferred shares.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Shareholder dilution
- Issuance of 408,334 unregistered common shares during the quarter, including 375,001 shares issued through conversion of 112,500 Series C preferred shares, creates potential dilution for existing common shareholders.
- Litigation costs and disruption
- The filing states that litigation can adversely affect the company through defense and settlement costs and management-resource diversion, although management reported no current proceedings likely to have a material adverse effect.
- Limited risk-factor update
- The company is a smaller reporting company and is not required to include risk factors in this 10-Q; it states there were no material changes to previously disclosed risks as of the filing date.
What they said about what is next.
The filing does not provide quantitative revenue, EPS, margin, liquidity, or capital-spending guidance. No forward outlook is disclosed in the provided MD&A text.
The filing reads about the same as the one before it.
What came before.
- 10-Q · August 8, 2026
- The supplied 10-Q excerpt is limited to Part II disclosures and does not contain the income statement, balance sheet, cash-flow statement, segment data, or MD&A needed to assess revenue, margins, EPS, liquidity, and…
- 10-Q · May 15, 2026
- CitroTech Inc. reported significant challenges in Q1 2026, with revenues plunging 64% year-over-year to $344,915 due to a lack of fire events driving demand, and a net loss of $6.21 million, though lower than the…
- 10-K · March 30, 2026
- CitroTech Inc.'s 2025 10-K report highlights significant growth in revenue, achieving $2.38 million, a 195% increase year-over-year. However, the company also reported a staggering net loss of $36.8 million, attributed…
- 10-Q · November 12, 2025
- CITR's revenue surged significantly, reporting $288,212 for Q3 2025, up 169% from $107,042 in Q3 2024, driven mainly by increased adoption of fire defense technologies. However, operating expenses ballooned to $4.5…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CITR makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever